Allurion SPAC Presentation Deck
A
Allurion Aims to Solve One of the Biggest Problems in Healthcare, is Growing at an
Exceptional Rate, and is Nearing Several Multi-Billion Dollar Catalysts
1
2
3
LO
Obesity is one of the biggest unmet medical needs in the world and new GLP-1 drugs
have unlocked a $50B+ revenue opportunity¹
5
Allurion delivers on average 30 pounds of weight loss and remission of Type 2 Diabetes in
just 4 months and 95% weight maintenance at 1-year²
4 Expanding generative Al platform with launch of Coach Iris, a 24/7 GPT-powered health coach
100,000+ patients treated in established distribution channels with clear path to 80%+ margins
Additional regulatory approvals, product pipeline, and digital platform expansion are
catalysts for future opportunities
Sources: 1) Morgan Stanley, "Unlocking the Obesity Challenge: a >$50BN Market"; 2) Obes Surg. 2020; 20(9):3354-62. lenca et al. Obesity Week 2020 and 2021.View entire presentation